ADENOCYSTIC CARCINOMA is an aggressive disease with a propensity for perineural, hematogenous, and lymphatic invasion. The prognosis is grim: approximately 70% to 80% of patients succumb to the disease within 10 years of diagnosis despite aggressive and often disfiguring treatment, and recurrences can occur 15 or 20 years after excision, making true cures extremely rare.1,2
Goldberg RA. Intra-arterial Chemotherapy: A Welcome New Idea for the Management of Adenocystic Carcinoma of the Lacrimal Gland. Arch Ophthalmol. 1998;116(3):372–373. doi:10.1001/archopht.116.3.372
Monkeypox Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.